Melanoma and NBL growth proceeded unchecked in tumor-bearing B6.SJL congenic mice treated with control, Il21r-/- or Cbx3-Il21r-deficient CD8+ effector T cells compared to animals receiving Cbx3/HP1γ-deficient CD8+ effector T cells (Figures 5E, G). Here, CD8A is linked to melanoma.